Literature DB >> 12460035

Family members of patients treated for ESRD have high rates of undetected kidney disease.

Claudine Jurkovitz1, Harold Franch, David Shoham, Judy Bellenger, William McClellan.   

Abstract

BACKGROUND: Early intervention during the course of chronic kidney disease (CKD) may delay the progression to end-stage renal disease (ESRD). Several studies have reported that relatives of patients with ESRD are at risk for kidney disease (KD), but little is known about the prevalence and awareness of CKD in this population, which is the object of this report.
METHODS: We conducted a cross-sectional survey by way of a voluntary screening of relatives of patients with ESRD in 10 communities in one southeastern state. Age; race; sex; family and personal history of KD, hypertension, and diabetes; height; weight; and blood pressure were determined. Proteinuria and random blood glucose and serum creatinine were measured. Creatinine clearance (CrCl) was assessed using the Cockroft-Gault formula.
RESULTS: Among 769 screened adults, 29.2% with a family history of ESRD were included in the study sample. CKD (CrCl < 90 mL/min) was present in 49.3%, 13.9% had a CrCl less than 60 mL/min, and 9.9% had proteinuria of 1+ or greater. Among those with a CrCl less than 60 mL/min or a proteinuria of 1+ or greater, or both, only 13.0% were aware of their KD. Awareness of CKD was not associated with age, race, sex, education, control of diabetes and hypertension, or physician's visits. Among those who had seen a physician recently, only 7.9% were aware of their KD.
CONCLUSION: Awareness of KD is less than expected among relatives of patients with ESRD considering the high prevalence of CKD in this population. Screening these individuals might help identify people with early KD. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460035     DOI: 10.1053/ajkd.2002.36866

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience.

Authors:  Heejung Bang; Madhu Mazumdar; George Newman; Andrew S Bomback; Christie M Ballantyne; Allan S Jaffe; Phyllis A August; Abhijit V Kshirsagar
Journal:  Nephrol Dial Transplant       Date:  2009-03-26       Impact factor: 5.992

2.  Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.

Authors:  Bamidele O Tayo; Holly Kramer; Babatunde L Salako; Omri Gottesman; Colin A McKenzie; Adesola Ogunniyi; Erwin P Bottinger; Richard S Cooper
Journal:  Int Urol Nephrol       Date:  2012-09-07       Impact factor: 2.370

3.  Familial risks of kidney failure in Sweden: a nationwide family study.

Authors:  Delshad Saleh Akrawi; Xinjun Li; Jan Sundquist; Kristina Sundquist; Bengt Zöller
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

4.  Albuminuria and Reduced Estimated Glomerular Filtration Rate among First-degree Relatives of Patients with Chronic Kidney Disease in Lagos, Southwest Nigeria.

Authors:  Y R Raji; M O Mabayoje; B T Bello; C O Amira
Journal:  Indian J Nephrol       Date:  2018 Jan-Feb

5.  Prevalence and Associated Factors of Chronic Kidney Disease among Relatives of Hemodialysis Patients in Saudi Arabia.

Authors:  Dujanah Mousa; Ali Alharbi; Imed Helal; Mohammed Al-Homrany; Fayez Alhujaili; Abdullah Alhweish; Mohammed A Marie; Abdulla Al Sayyari
Journal:  Kidney Int Rep       Date:  2021-01-13

6.  Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China.

Authors:  Xianglei Kong; Li Liu; Li Zuo; Ping Yuan; Zhongxin Li; Wenge Li; Meishun Cai; Xiangmei Chen; Aili Jiang; Gang Long; Jinsheng Xu; Hongli Lin; Shixiang Wang; Wen Huang; Yiping Wang; Yidan Guo; Po Cao; Hua Wu; Qiang Jia; Luxia Zhang; Mei Wang; Haiyan Wang
Journal:  BMC Nephrol       Date:  2013-01-18       Impact factor: 2.388

7.  Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.

Authors:  Jiun-Chi Huang; Szu-Chia Chen; Ming-Yen Lin; Jer-Ming Chang; Shang-Jyh Hwang; Jer-Chia Tsai; Hung-Chun Chen
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.